BREAKTHROUGH IN THERAPY..

For those of us visually disabled, we are greatly encouraged by the great strides reflected in research. Here’s the latest from Nanoscope Therapeutics…

https://nanostherapeutics.com/2021/07/19/nanoscope-therapeutics-announces-first-patient-dosed-in-phase-2b-clinical-trial-of-optogenetic-gene-monotherapy-to-restore-vision-in-patients-with-retinitis-pigmentosa/